🟢 Neumora Therapeutics is trading 12.33% up in pre-market as U.S. equities gain

Neumora Therapeutics is trading at $0.82, up 12.33%, after broader risk-on sentiment lifted U.S. equities on September 21, 2026.

• S&P 500 and Nasdaq Composite futures are up more than 0.5%, supporting biotech risk appetite
• No fresh company-specific announcement was identified for September 21
• Earlier NMRA-215 toxicology news is dated July 27, not a new catalyst